We've stocked up — ready for next-day dispatch Australia-wide.

KLOW Peptide Blend 50mg 80mg · Lyophilised — Research Peptide Australia — 99.0% HPLC Purity
Pre-Order

KLOW Peptide Blend 50mg

Blends80mg · LyophilisedBatch: PW-260305
99.0% HPLC PurityCOA Verified ✓
$159.99AUD
Pre-Order Available
Qty
1

Only 0 in stock. 0 will ship immediately — 1 will be fulfilled as a pre-order.

Free shipping on orders over $199 AUD

Australia Post tracked — Standard $9.99 / Express $14.99

Dispatched next business day (orders before 11PM AEST)

COA available — Batch PW-260305

Product Details

Advanced Multi-Peptide Research Formula

KLOW Peptide Blend is available in Australia from Peptide Warehouse with fast domestic shipping to all states and territories.

KLOW is an exclusive Peptide Warehouse formula that combines multiple carefully selected research peptides in a single lyophilised preparation. It was designed for researchers who want to study the combined effect of multiple healing and recovery compounds working together, rather than running separate protocols for each peptide. The full composition is disclosed in the Certificate of Analysis for complete research transparency. The 50mg vial provides ample material for extended protocols without the need for frequent reordering.

What KLOW Is Studied For

  • Multi-pathway tissue repairCombines peptides with complementary healing mechanisms so researchers can study synergistic effects across multiple repair pathways at once.
  • Recovery researchDesigned for complex preclinical models where a single peptide approach doesn't capture the full picture of the biological process under study.
  • Convenience and consistencySingle reconstitution from one vial with pre-verified ratios, removing the complexity of preparing and blending multiple compounds separately.
  • Synergistic peptide interactionsAllows investigation of how multiple research peptides interact and influence each other's activity in the same biological system.

Supplied as lyophilised powder at 99.0% HPLC purity, independently verified by third-party testing. 50mg per vial. Fast domestic shipping across Australia from our Melbourne warehouse — batch-specific COA available in our COA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.

Key Research Features

Frequently Asked Questions — KLOW Peptide Blend

KLOW is an advanced multi-peptide research blend from Peptide Warehouse. Full composition details — including each peptide component and ratio — are available in the Certificate of Analysis in our COA Library.

The KLOW Blend (Batch PW-260305) is verified at 99.0% HPLC purity across all components. Because KLOW is a multi-peptide formulation, quality testing is more comprehensive than single-peptide products. The COA includes: HPLC purity for the combined blend and individual components, mass spectrometry identity confirmation for each peptide, for the combined preparation, sterility screening, and a full component breakdown. The blend is sourced and prepared under GMP-certified conditions with full chain-of-custody documentation.

Yes. KLOW is legal to purchase in Australia for laboratory research purposes. All component peptides are research-grade compounds not scheduled under the Poisons Standard when sold for research use only. Not for human consumption, therapeutic, cosmetic, or veterinary use. Purchasers must be 18+.

Storage: Lyophilised KLOW (50mg) should be stored at −20°C, protected from moisture and light, for up to 24 months. The 50mg size provides substantial material for extended research protocols without frequent reordering. Reconstitution: Add bacteriostatic water slowly (2–5mL depending on desired working concentration) using a 31G syringe, injecting down the inner vial wall. Gently swirl to dissolve. Do not shake. Reconstituted solution should be stored at 2–8°C and used within 4 weeks. Due to the multi-peptide composition, we recommend reviewing the COA component list before determining your working concentration.

The full component breakdown of the KLOW Blend is proprietary but is fully disclosed in the Certificate of Analysis (COA) for Batch PW-260305, available in our COA Library. Researchers requiring component identity for institutional ethics approval or laboratory documentation should download the COA directly or contact info@auspeptidewarehouse.com.au. Each component is independently verified for identity by mass spectrometry and for purity by HPLC before blending. Not for human consumption — for research use only.

The 50mg format reflects the multi-peptide nature of KLOW — the total weight represents the combined mass of all component peptides. Because the blend contains multiple peptides, each individual component is present at a fraction of the total 50mg weight. The 50mg total size ensures that each component is present in a research-useful quantity for extended protocols without requiring frequent reordering. It also allows researchers to prepare multiple working concentrations or run parallel assays from a single vial. Not for human consumption — for research use only.

Working concentration calculation for KLOW requires reference to the COA component breakdown, which lists each peptide and its proportion of the total 50mg blend. Example: if Component A represents 40% of the blend, a 10mg/mL total KLOW solution contains 4mg/mL of Component A. Molar concentration for each component can then be calculated using its individual molecular weight. We recommend downloading the COA from our COA Library before preparing your dilution series. BAC water (available at /products/bac-water-10ml) and 31G insulin needles (/products/insulin-needles-31g) are required for reconstitution. Not for human consumption — for research use only.

Yes. KLOW is an original Peptide Warehouse blend formulated specifically for our research catalogue. The component selection, ratios, and lyophilisation process are proprietary. While the specific components are disclosed in the COA for transparency and research documentation purposes, the formulation itself is exclusive to Peptide Warehouse. Not for human consumption — for research use only.

KLOW is designed for complex multi-pathway research protocols where a single-peptide preparation is insufficient to model the biological question under study. The component peptides were selected based on their complementary mechanisms, allowing researchers to investigate synergistic pathway interactions in a single, standardised preparation. Specific application areas are defined by the component peptide profile disclosed in the COA. Not for human consumption — for research use only.

KLOW can be used alongside other individual peptides in research settings — each compound should be reconstituted separately and combined at the point of use according to your protocol. Researchers wishing to supplement KLOW with additional BPC-157 (/products/bpc-157-10mg), GHK-Cu (/products/ghk-cu-50mg), Semax (/products/semax-10mg), or other individual peptides from our catalogue may do so based on their experimental design. Always prepare a fresh dilution series and verify concentration calculations from the COA. Not for human consumption — for research use only.

The COA for KLOW (Batch PW-260305) includes: HPLC purity analysis showing purity % for the combined preparation and individual component peaks; mass spectrometry identity confirmation for each component peptide, with observed and theoretical molecular weights; sterility screening (LAL endotoxin test and microbial sterility); a full component list with weight/percentage breakdown; manufacturing facility GMP certification reference; and batch-specific production date and expiry. The COA is publicly available in our COA Library. Not for human consumption — for research use only.

KLOW offers several practical advantages over purchasing and blending individual peptides independently: single reconstitution from one vial rather than multiple; pre-verified component ratios with COA documentation; cost efficiency compared to buying equivalent amounts of each component separately; and reduced pipetting steps and associated error in research preparation. The trade-off is fixed ratios — if your protocol requires components at different ratios than the KLOW formulation, individual peptides give more flexibility. For standardised multi-peptide research protocols, KLOW is the more efficient choice. Not for human consumption — for research use only.

Frequently Bought Together

BPC-157 + TB-500 Blend 10mg 10mg · Lyophilised — 99.0% HPLC Purity — Research Peptide Australia
6 left

BPC-157 + TB-500 Blend

Healing10mg · Lyophilised
$129.99AUD
CJC-1295 + Ipamorelin 10mg 10mg · Lyophilised — 99.0% HPLC Purity — Research Peptide Australia

CJC-1295 + Ipamorelin

Blends10mg · Lyophilised
$129.99AUD